Personal Home Page

http://www.utoronto.ca/acdclab/epdpubs.htm

Articles in Scholarly Journals [Incomplete List]

1. Seminal Plasma Lipocalin-Type Prostaglandin D Synthase: A Potential New Marker for the Diagnosis of Obstructive Azoospermia
   The Journal of Urology, vol. 179, no. 3, pp. 1077–1080, 2008
2. Androgens act synergistically to enhance estrogen-induced upregulation of human tissue kallikreins 10, 11, and 14 in breast cancer cells via a membrane bound androgen receptor
   Molecular Oncology, vol. 1, no. 4, pp. 413–424, 2008
3. “Product Ion Monitoring” Assay for Prostate-Specific Antigen in Serum Using a Linear Ion-Trap
   Journal of Proteome Research, vol. 7, no. 2, pp. 640–647, 2008
4. A Multiparametric Serum Kallikrein Panel for Diagnosis of Non-Small Cell Lung Carcinoma
   Clinical Cancer Research, vol. 14, no. 5, pp. 1355–1362, 2008
5. Mitochondrial Genome Deletion Aids in the Identification of False- and True-Negative Prostate Needle Core Biopsy Specimens
   American Journal of Clinical Pathology, vol. 129, no. 1, pp. 57–66, 2008
6. Discovery of Candidate Tumor Markers for Prostate Cancer via Proteomic Analysis of Cell Culture-Conditioned Medium
   Clinical Chemistry, vol. 53, no. 3, pp. 429–437, 2007
7. Oncopeptidomics: A Useful Approach for Cancer Diagnosis?
   Clinical Chemistry, vol. 53, no. 6, pp. 1004–1006, 2007
8. Distribution of 15 Human Kallikreins in Tissues and Biological Fluids
   Clinical Chemistry, vol. 53, no. 8, pp. 1423–1432, 2007
9. Validation and Characterization of Human Kallikrein 11 as a Serum Marker for Diagnosis of Ovarian Carcinoma
   Clinical Cancer Research, vol. 13, no. 15, pp. 4422–4428, 2007
10. Primary Tumor Levels of Human Tissue Kallikreins Affect Surgical Success and Survival in Ovarian Cancer Patients
    Clinical Cancer Research, vol. 13, no. 6, pp. 1742–1748, 2007
11. A Multiparametric Panel for Ovarian Cancer Diagnosis, Prognosis, and Response to Chemotherapy
    Clinical Cancer Research, vol. 13, no. 23, pp. 6984–6992, 2007
12. Aberrant human tissue kallikrein levels in the stratum corneum and serum of patients with psoriasis: dependence on phenotype, severity and therapy
    British Journal of Dermatology, vol. 156, no. 5, pp. 875–883, 2007
13. Human Kallikrein-related Peptidase 14 (KLK14) Is a New Activator Component of the KLK Proteolytic Cascade: POSSIBLE FUNCTION IN SEMINAL PLASMA AND SKIN
    Journal of Biological Chemistry, vol. 283, no. 6, pp. 3031–3041, 2007
14. Proteomics Analysis of Conditioned Media from Three Breast Cancer Cell Lines: A Mine for Biomarkers and Therapeutic Targets
    Molecular & Cellular Proteomics, vol. 6, no. 11, pp. 1997–2011, 2007
15. Proteomics Analysis of Human Amniotic Fluid
    Molecular & Cellular Proteomics, vol. 6, no. 8, pp. 1406–1415, 2007
16. Human tissue kallikrein expression in the stratum corneum and serum of atopic dermatitis patients
    Experimental Dermatology, vol. 16, no. 6, pp. 513–519, 2007
17. Proteomic Analysis of Human Cervico-Vaginal Fluid
    Journal of Proteome Research, vol. 6, no. 7, pp. 2859–2865, 2007
18. Transcriptional upregulation of human tissue kallikrein 6 in ovarian cancer: clinical and mechanistic aspects
    British Journal of Cancer, vol. 96, no. 2, Article ID 6603556, 10 pages, 2007
19. Correlation between SPINK5 Gene Mutations and Clinical Manifestations in Netherton Syndrome Patients
    Journal of Investigative Dermatology, vol. 128, no. 5, Article ID 5701153, 11 pages, 2007
20. A consolidated catalogue and graphical annotation of dbSNP polymorphisms in the human tissue kallikrein (KLK) locus
    Molecular Oncology, vol. 1, no. 3, pp. 303–312, 2007
21. New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
    Molecular Oncology, vol. 1, no. 3, pp. 269–287, 2007
22. Ovarian cancer specific kallikrein profile in effusions
    Gynecologic Oncology, vol. 105, no. 2, pp. 501–507, 2007
23. B7-H4 is over-expressed in early-stage ovarian cancer and is independent of CA125 expression
    Gynecologic Oncology, vol. 106, no. 2, pp. 334–341, 2007
24. An experimental strategy for quantitative analysis of the humoral immune response to prostate cancer antigens using natural protein microarrays
    PROTEOMICS – Clinical Applications, vol. 1, no. 5, pp. 494–505, 2007
25. Human kallikrein-related peptidase 12: Antibody generation and immunohistochemical localization in prostatic tissues
    The Prostate, vol. 67, no. 13, pp. 1465–1474, 2007
26. Humane Kallikreine als Tumormarker
    Der Urologe, vol. 46, no. 9, pp. 1070–1071, 2007
27. Assay-specific artificial neural networks for five different PSA assays and populations with PSA 2–10 ng/ml in 4,480 men
    World Journal of Urology, vol. 25, no. 1, pp. 95–103, 2007
28. Human tissue kallikreins: The cancer biomarker family?
    Cancer Letters, vol. 249, no. 1, pp. 61–79, 2007
29. Cancer biomarkers
    Cancer Letters, vol. 249, no. 1, pp. 1–2, 2007
30. High throughput proteomic strategies for identifying tumour-associated antigens
    Cancer Letters, vol. 249, no. 1, pp. 110–119, 2007
31. Proteolytic processing of human growth hormone by multiple tissue kallikreins and regulation by the serine protease inhibitor Kazal-Type5 (SPINK5) protein
    Clinica Chimica Acta, vol. 377, no. 1-2, pp. 228–236, 2007
32. Human tissue kallikreins: A road under construction
    Clinica Chimica Acta, vol. 381, no. 1, pp. 78–84, 2007
33. Development of an immunofluorometric assay for human kallikrein 15 (KLK15) and identification of KLK15 in tissues and biological fluids
    Clinical Biochemistry, vol. 40, no. 1-2, pp. 104–110, 2007
34. POINT: EPCA-2: A promising new serum biomarker for prostatic carcinoma?
    Clinical Biochemistry, vol. 40, no. 18, pp. 1437–1439, 2007
35. PSA and other tissue kallikreins for prostate cancer detection
    European Journal of Cancer, vol. 43, no. 13, pp. 1918–1926, 2007
36. Enzymatic properties of human kallikrein-related peptidase 12 (KLK12)
    Biological Chemistry, vol. 388, no. 4, pp. 427–435, 2007
37. Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines
    Biological Chemistry, vol. 388, no. 10, pp. 1113–1119, 2007
38. Defining the extended substrate specificity of kallikrein 1-related peptidases
    Biological Chemistry, vol. 388, no. 11, pp. 1215–1225, 2007
39. Somatic Mitochondrial DNA Mutations in Prostate Cancer and Normal Appearing Adjacent Glands in Comparison to Age-Matched Prostate Samples without Malignant Histology
    Journal of Molecular Diagnostics, vol. 8, no. 3, pp. 312–319, 2006
40. Quality of the scientific literature: All that glitters is not gold
    Clinical Biochemistry, vol. 39, no. 12, pp. 1109–1111, 2006
41. Coordinated steroid hormone-dependent and independent expression of multiple kallikreins in breast cancer cell lines
    Breast Cancer Research and Treatment, vol. 102, no. 1, pp. 7–18, 2006
42. Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
    American Journal of Obstetrics and Gynecology, vol. 194, no. 5, pp. 1296–1302, 2006
43. Three new serum markers for prostate cancer detection within a percent free PSA-based artificial neural network
    The Prostate, vol. 66, no. 6, pp. 651–659, 2006
44. In silico identification and Bayesian phylogenetic analysis of multiple new mammalian kallikrein gene families
    Genomics, vol. 88, no. 5, pp. 591–599, 2006
45. Mass Spectrometry: Uncovering the Cancer Proteome for Diagnostics
    Advances in Cancer Research, vol. 96, pp. 23–50, 2006
46. Expression of human Kallikrein 14 (KLK14) in breast cancer is associated with higher tumour grades and positive nodal status
    British Journal of Cancer, vol. 94, no. 4, Article ID 6602956, 7 pages, 2006
47. Quantification of Eight Tissue Kallikreins in the Stratum Corneum and Sweat
    Journal of Investigative Dermatology, vol. 126, no. 4, Article ID 5700146, 4 pages, 2006
48. Elevated Human Tissue Kallikrein Levels in the Stratum Corneum and Serum of Peeling Skin Syndrome-Type B Patients Suggests an Over-desquamation of Corneocytes
    Journal of Investigative Dermatology, vol. 126, no. 10, Article ID 5700379, 4 pages, 2006
49. Journal of Proteome Research, vol. 5, no. 9, pp. 2079–2082, 2006
50. Mutant recombinant serpins as highly specific inhibitors of human kallikrein 14
    FEBS Journal, vol. 273, no. 11, pp. 2505–2514, 2006
51. Serum Proteomic Profiling by Matrix-Assisted Laser Desorption-Ionization Time-of-Flight Mass Spectrometry for Cancer Diagnosis: Next Steps
    Cancer Research, vol. 66, no. 11, pp. 5540–5541, 2006
52. Proteinase-activated Receptors, Targets for Kallikrein Signaling
    Journal of Biological Chemistry, vol. 281, no. 43, pp. 32095–32112, 2006
53. Human Tissue Kallikrein 5 Is a Member of a Proteolytic Cascade Pathway Involved in Seminal Clot Liquefaction and Potentially in Prostate Cancer Progression
    Journal of Biological Chemistry, vol. 281, no. 18, pp. 12743–12750, 2006
54. A Potential Role for Multiple Tissue Kallikrein Serine Proteases in Epidermal Desquamation
    Journal of Biological Chemistry, vol. 282, no. 6, pp. 3640–3652, 2006
55. Expression and Functional Characterization of the Cancer-related Serine Protease, Human Tissue Kallikrein 14
    Journal of Biological Chemistry, vol. 282, no. 4, pp. 2405–2422, 2006
56. Serum human glandular kallikrein 2 (hK2) for distinguishing stage and grade of prostate cancer
    International Journal of Urology, vol. 13, no. 3, pp. 238–243, 2006
57. Measurement of Serum Levels of Macrophage Inhibitory Cytokine 1 Combined with Prostate-Specific Antigen Improves Prostate Cancer Diagnosis
    Clinical Cancer Research, vol. 12, no. 1, pp. 89–96, 2006
58. Purification and Characterization of Human Kallikrein 11, a Candidate Prostate and Ovarian Cancer Biomarker, from Seminal Plasma
    Clinical Cancer Research, vol. 12, no. 3, pp. 742–750, 2006
59. Lost in (the Business of) Translation: Invest in the Youth
    Clinical Cancer Research, vol. 12, no. 2, pp. 669–669, 2006
60. Human Kallikrein 8 Protein Is a Favorable Prognostic Marker in Ovarian Cancer
    Clinical Cancer Research, vol. 12, no. 5, pp. 1487–1493, 2006
61. Proteomic and Genomic Technologies for Biomarker Discovery: Where Are the Biomarkers?
    Clinical Proteomics, vol. 2, no. 1-2, pp. 5–12, 2006
62. Comparison of Methods to Examine the Endogenous Peptides of Fetal Calf Serum
    Clinical Proteomics, vol. 2, no. 1-2, pp. 67–90, 2006
63. Validation of Breast Cancer Biomarkers Identified by Mass Spectrometry
    Clinical Chemistry, vol. 52, no. 4, pp. 771–772, 2006
64. Effect of Testosterone Administration on Serum and Urine Kallikrein Concentrations in Female-to-Male Transsexuals
    Clinical Chemistry, vol. 52, no. 8, pp. 1546–1551, 2006
65. Serum and Urine Tissue Kallikrein Concentrations in Male-to-Female Transsexuals Treated with Antiandrogens and Estrogens
    Clinical Chemistry, vol. 52, no. 7, pp. 1356–1365, 2006
66. Unfavorable Prognostic Value of Human Kallikrein 7 Quantified by ELISA in Ovarian Cancer Cytosols
    Clinical Chemistry, vol. 52, no. 10, pp. 1879–1886, 2006
67. The First International Symposium on Kallikreins
    Biological Chemistry, vol. 387, no. 6, pp. 635–636, 2006
68. A comprehensive nomenclature for serine proteases with homology to tissue kallikreins
    Biological Chemistry, vol. 387, no. 6, pp. 637–641, 2006
69. The kallikrein world: an update on the human tissue kallikreins
    Biological Chemistry, vol. 387, no. 6, pp. 643–652, 2006
70. Cellular distribution of human tissue kallikreins: immunohistochemical localization
    Biological Chemistry, vol. 387, no. 6, pp. 653–663, 2006
71. Proteinase-mediated cell signalling: targeting proteinase-activated receptors (PARs) by kallikreins and more
    Biological Chemistry, vol. 387, no. 6, pp. 677–685, 2006
72. Activation and enzymatic characterization of recombinant human kallikrein 8
    Biological Chemistry, vol. 387, no. 6, pp. 723–731, 2006
73. Human tissue kallikrein 9: production of recombinant proteins and specific antibodies
    Biological Chemistry, vol. 387, no. 6, pp. 733–740, 2006
74. Human kallikrein 4: enzymatic activity, inhibition, and degradation of extracellular matrix proteins
    Biological Chemistry, vol. 387, no. 6, pp. 749–759, 2006
75. The epigenetic basis for the aberrant expression of kallikreins in human cancers
    Biological Chemistry, vol. 387, no. 6, pp. 795–799, 2006
76. Improved prostate cancer detection with a human kallikrein 11 and percentage free PSA-based artificial neural network
    Biological Chemistry, vol. 387, no. 6, pp. 801–805, 2006
77. Overexpression of the human tissue kallikrein genes
    Biological Chemistry, vol. 387, no. 6, pp. 807–811, 2006
78. Kallikrein-mediated cell signalling: targeting proteinase-activated receptors (PARs)
    Biological Chemistry, vol. 387, no. 6, pp. 817–824, 2006
79. Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma
    Biological Chemistry, vol. 387, no. 8, pp. 1121–1128, 2006
80. The role of human tissue kallikreins 7 and 8 in intracranial malignancies
    Biological Chemistry, vol. 387, no. 12, pp. 1607–1612, 2006
81. Effects of Long-term Androgen Administration on Breast Tissue of Female-to-Male Transsexuals
    Journal of Histochemistry and Cytochemistry, vol. 54, no. 8, pp. 905–910, 2006
82. Prognostic Implications of the Immunohistochemical Expression of Human Kallikreins 5, 6, 10 and 11 in Renal Cell Carcinoma
    Tumor Biology, vol. 27, no. 1, pp. 1–7, 2006
83. Kallikreins as Markers of Disseminated Tumour Cells in Ovarian Cancer – A Pilot Study
    Tumor Biology, vol. 27, no. 2, pp. 104–114, 2006
84. Characterization of Human Kallikreins 6 and 10 in Ascites Fluid from Ovarian Cancer Patients
    Tumor Biology, vol. 27, no. 5, pp. 227–234, 2006
85. Identification of New Splice Variants and Differential Expression of the Human Kallikrein 10 Gene, a Candidate Cancer Biomarker
    Tumor Biology, vol. 26, no. 5, pp. 227–235, 2005
86. Downregulation of Human Kallikrein 10 (KLK10/NES1) by CpG Island Hypermethylation in Breast, Ovarian and Prostate Cancers
    Tumor Biology, vol. 26, no. 6, pp. 324–336, 2005
87. Human Kallikrein 6 Expression in Salivary Gland Tumors
    Journal of Histochemistry and Cytochemistry, vol. 54, no. 3, pp. 337–342, 2005
88. Clinical utility of human glandular kallikrein 2 within a neural network for prostate cancer detection
    BJU International, vol. 96, no. 4, pp. 521–527, 2005
89. Human Kallikrein 6: A New Potential Serum Biomarker for Uterine Serous Papillary Cancer
    Clinical Cancer Research, vol. 11, no. 9, pp. 3320–3325, 2005
90. Quantification of Human Tissue Kallikreins in the Stratum Corneum: Dependence on Age and Gender
    Journal of Investigative Dermatology, vol. 125, no. 6, pp. 1182–1189, 2005
91. Multiple tissue kallikrein mRNA and protein expression in normal skin and skin diseases
    British Journal of Dermatology, vol. 153, no. 2, pp. 274–281, 2005
92. Biochemical and Enzymatic Characterization of Human Kallikrein 5 (hK5), a Novel Serine Protease Potentially Involved in Cancer Progression
    Journal of Biological Chemistry, vol. 280, no. 15, pp. 14628–14635, 2005
93. Potential markers that complement expression of CA125 in epithelial ovarian cancer
    Gynecologic Oncology, vol. 99, no. 2, pp. 267–277, 2005
94. A survey of alternative transcripts of human tissue kallikrein genes
    Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2005
95. Enzymatic profiling of human kallikrein 14 using phage-display substrate technology
    Biological Chemistry, vol. 386, no. 3, pp. 291–298, 2005
96. Intron Retention: A Common Splicing Event within the Human Kallikrein Gene Family
    Clinical Chemistry, vol. 51, no. 3, pp. 506–515, 2005
97. Human Kallikrein 4: Quantitative Study in Tissues and Evidence for Its Secretion into Biological Fluids
    Clinical Chemistry, vol. 51, no. 8, pp. 1432–1442, 2005
98. Proteomic patterns to identify ovarian cancer: 3 years on
    Expert Review of Molecular Diagnostics, vol. 4, no. 5, pp. 575–577, 2004
99. Cloning and characterization of novel isoforms of the human kallikrein 6 gene1, 2, 3
    Biochemical and Biophysical Research Communications, vol. 320, no. 1, pp. 54–61, 2004
100. Human kallikrein 13 involvement in extracellular matrix degradation
     Biochemical and Biophysical Research Communications, vol. 323, no. 3, pp. 1084–1090, 2004
101. Human tissue kallikrein gene family: applications in cancer
     Cancer Letters, 2004
102. Sequence and evolutionary analysis of the human trypsin subfamily of serine peptidases
     Biochimica et Biophysica Acta (BBA) - Proteins & Proteomics, vol. 1698, no. 1, pp. 77–86, 2004
103. Complex formation between human kallikrein 13 and serum protease inhibitors
     Clinica Chimica Acta, vol. 339, no. 1-2, pp. 157–167, 2004
104. Prostate-specific antigen expression in nipple aspirate fluid is associated with advanced breast cancer
     Cancer Detection and Prevention, vol. 28, no. 1, pp. 27–31, 2004
105. Altered kallikrein 7 and 10 concentrations in cerebrospinal fluid of patients with Alzheimer's disease and frontotemporal dementia
     Clinical Biochemistry, vol. 37, no. 3, pp. 230–237, 2004
106. An update on human and mouse glandular kallikreins
     Clinical Biochemistry, vol. 37, no. 4, pp. 258–260, 2004
107. Immunoassay interference: a relatively rare but still important problem
     Clinical Biochemistry, vol. 37, no. 5, pp. 331–332, 2004
108. Human kallikrein 11: an indicator of favorable prognosis in ovarian cancer patients
     Clinical Biochemistry, vol. 37, no. 9, pp. 823–829, 2004
109. Recent Advances in Cancer Biomarkers
     Clinical Biochemistry, vol. 37, no. 7, pp. 503–504, 2004
110. Cloning of a kallikrein pseudogene
     Clinical Biochemistry, vol. 37, no. 11, pp. 961–967, 2004
111. Kallikrein gene downregulation in breast cancer
     British Journal of Cancer, vol. 90, no. 1, Article ID 6601451, 5 pages, 2004
112. OvaCheck: doubts voiced soon after publication
     Nature, vol. 430, no. 7000, Article ID 430611c, 1 pages, 2004
113. The emerging roles of human tissue kallikreins in cancer
     Nature Reviews Cancer, vol. 4, no. 11, Article ID nrc1474, 14 pages, 2004
114. Hepsin is Highly Over Expressed in and a New Candidate for a Prognostic Indicator in Prostate Cancer
     The Journal of Urology, vol. 171, no. 1, pp. 187–191, 2004
115. Re: Diagnostic Potential of Serum Proteomic Patterns in Prostate Cancer
     The Journal of Urology, vol. 171, no. 3, pp. 1244–1245, 2004
116. Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker for Nasopharyngeal Carcinoma
     Clinical Cancer Research, vol. 10, no. 15, pp. 5293–5294, 2004
117. Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery Tool: Opportunities and Potential Limitations
     Molecular & Cellular Proteomics, vol. 3, no. 4, pp. 367–378, 2004
118. Assessment of serum prostate specific antigen in childhood
     BJU International, vol. 93, no. 6, pp. 838–840, 2004
119. Molecular Cloning of a New Gene Which Is Differentially Expressed in Breast and Prostate Cancers
     Tumor Biology, vol. 25, no. 3, pp. 122–133, 2004
120. Differential Expression of a Human Kallikrein 5 (KLK5) Splice Variant in Ovarian and Prostate Cancer
     Tumor Biology, vol. 25, no. 3, pp. 149–156, 2004
121. Human Kallikrein 6 Degrades Extracellular Matrix Proteins and May Enhance the Metastatic Potential of Tumour Cells
     Tumor Biology, vol. 25, no. 4, pp. 193–199, 2004
122. The Kallikrein Gene 5 Splice Variant 2 Is a New Biomarker for Breast and Ovarian Cancer
     Tumor Biology, vol. 25, no. 5-6, pp. 221–227, 2004
123. In silico Analysis of the Human Kallikrein Gene 6
     Tumor Biology, vol. 25, no. 5-6, pp. 282–289, 2004
124. Development of an Immunofluorometric Assay and Quantification of Human Kallikrein 7 in Tissue Extracts and Biological Fluids
     Clinical Chemistry, vol. 50, no. 4, pp. 709–716, 2004
125. How Are We Going to Discover New Cancer Biomarkers? A Proteomic Approach for Bladder Cancer
     Clinical Chemistry, vol. 50, no. 5, pp. 793–795, 2004
126. Human Kallikrein 13 Protein in Ovarian Cancer Cytosols: A New Favorable Prognostic Marker
     Journal of Clinical Oncology, vol. 22, no. 4, pp. 678–685, 2004
127. Immunofluorometric Quantification of Human Kallikrein 5 Expression in Ovarian Cancer Cytosols and Its Association with Unfavorable Patient Prognosis
     Tumor Biology, vol. 24, no. 6, pp. 299–309, 2003
128. Human Kallikrein 6 (hK6): A New Potential Serum Biomarker for Diagnosis and Prognosis of Ovarian Carcinoma
     Journal of Clinical Oncology, vol. 21, no. 6, pp. 1035–1043, 2003
129. Prognostic Value of the Human Kallikrein Gene 15 Expression in Ovarian Cancer
     Journal of Clinical Oncology, vol. 21, no. 16, pp. 3119–3126, 2003
130. Single Nucleotide Polymorphism of the Human Kallikrein-2 Gene Highly Correlates With Serum Human Kallikrein-2 Levels and in Combination Enhances Prostate Cancer Detection
     Journal of Clinical Oncology, vol. 21, no. 12, pp. 2312–2319, 2003
131. Human Kallikrein 13: Production and Purification of Recombinant Protein and Monoclonal and Polyclonal Antibodies, and Development of a Sensitive and Specific Immunofluorometric Assay
     Clinical Chemistry, vol. 49, no. 1, pp. 77–86, 2003
132. Human Kallikrein 8: Immunoassay Development and Identification in Tissue Extracts and Biological Fluids
     Clinical Chemistry, vol. 49, no. 1, pp. 87–96, 2003
133. Purification of Human Kallikrein 6 from Biological Fluids and Identification of its Complex with  1-Antichymotrypsin
     Clinical Chemistry, vol. 49, no. 5, pp. 746–751, 2003
134. Proteomic Patterns in Biological Fluids: Do They Represent the Future of Cancer Diagnostics?
     Clinical Chemistry, vol. 49, no. 8, pp. 1272–1275, 2003
135. Breast Cancer Research and Treatment, vol. 78, no. 2, pp. 149–158, 2003
136. Human tissue kallikreins and testicular cancer
     APMIS, vol. 111, no. 1, pp. 225–233, 2003
137. Quantitative analysis of macrophage inhibitory cytokine-1 (MIC-1) gene expression in human prostatic tissues
     British Journal of Cancer, vol. 88, no. 7, Article ID 6600869, 3 pages, 2003
138. Immunohistochemical localization of human kallikreins 6, 10 and 13 in benign and malignant prostatic tissues
     Prostate Cancer and Prostatic Diseases, vol. 6, no. 3, Article ID 4500674, 4 pages, 2003
139. Genomic overview of serine proteases
     Biochemical and Biophysical Research Communications, vol. 305, no. 1, pp. 28–36, 2003
140. Characterization of the enzymatic activity of human kallikrein 6: autoactivation, substrate specificity, and regulation by inhibitors
     Biochemical and Biophysical Research Communications, vol. 307, no. 4, pp. 948–955, 2003
141. Role of kallikrein enzymes in the central nervous system
     Clinica Chimica Acta, vol. 329, no. 1-2, pp. 1–8, 2003
142. Prognostic value of quantitatively assessed KLK7 expression in ovarian cancer
     Clinical Biochemistry, vol. 36, no. 2, pp. 135–143, 2003
143. An overview of the kallikrein gene families in humans and other species: emerging candidate tumour markers
     Clinical Biochemistry, vol. 36, no. 6, pp. 443–452, 2003
144. Quantitative Analysis of Kallikrein 15 Gene Expression in Prostate Tissue
     The Journal of Urology, vol. 169, no. 1, pp. 361–364, 2003
145. Quantitative analysis of hippostasin/KLK11 gene expression in cancerous and noncancerous prostatic tissues
     Urology, vol. 61, no. 5, pp. 1042–1046, 2003
146. The human kallikrein protein 5 (hK5) is enzymatically active, glycosylated and forms complexes with two protease inhibitors in ovarian cancer fluids
     Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression, vol. 1628, no. 2, pp. 88–96, 2003
147. Molecular characterization of a new gene, CEAL1, encoding for a carcinoembryonic antigen-like protein with a highly conserved domain of eukaryotic translation initiation factors
     Gene, vol. 310, pp. 79–89, 2003
148. Secretion of endogenous kallikreins 2 and 3 by androgen receptor-transfected PC-3 prostate cancer cells
     The Journal of Steroid Biochemistry and Molecular Biology, 2003
149. Steroid hormone regulation of the human kallikrein 10 (KLK10) gene in cancer cell lines and functional characterization of the KLK10 gene promoter
     Clinica Chimica Acta, vol. 337, no. 1-2, pp. 115–126, 2003
150. Differential expression of the human kallikrein gene 14 (KLK14) in normal and cancerous prostatic tissues
     The Prostate, vol. 56, no. 4, pp. 287–292, 2003
151. Favorable prognostic value of tissue human kallikrein 11 (hK11) in patients with ovarian carcinoma
     International Journal of Cancer, vol. 106, no. 4, pp. 605–610, 2003
152. Association of kallikrein expression in nipple aspirate fluid with breast cancer risk
     International Journal of Cancer, vol. 108, no. 4, pp. 588–591, 2003
153. Human Kallikreins: Common Structural Features, Sequence Analysis and Evolution
     Current Genomics, vol. 4, no. 2, pp. 147–165, 2003
154. Cockayne syndrome in three sisters with varying clinical presentation
     American Journal of Medical Genetics, vol. 111, no. 1, pp. 81–85, 2002